Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (166)
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
519
Price
$85.84
Total Value
$44.55K
Shares Held After
105,873
% of Holdings
0.5%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
833
Price
$84.41
Total Value
$70.31K
Shares Held After
106,392
% of Holdings
0.8%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
313
Price
$83.10
Total Value
$26.01K
Shares Held After
107,225
% of Holdings
0.3%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
8,660
Price
$18.71
Total Value
$162.03K
Shares Held After
409,897
% of Holdings
2.1%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,710
Price
$124.79
Total Value
$213.39K
Shares Held After
194,309
% of Holdings
0.9%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,975
Price
$123.74
Total Value
$244.39K
Shares Held After
196,019
% of Holdings
1.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
4,181
Price
$122.34
Total Value
$511.50K
Shares Held After
197,994
% of Holdings
2.1%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
12,134
Price
$121.65
Total Value
$1.48M
Shares Held After
202,175
% of Holdings
5.7%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
300
Price
$124.94
Total Value
$37.48K
Shares Held After
42,181
% of Holdings
0.7%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
528
Price
$123.84
Total Value
$65.39K
Shares Held After
42,481
% of Holdings
1.2%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,048
Price
$122.43
Total Value
$128.31K
Shares Held After
43,009
% of Holdings
2.4%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
3,124
Price
$121.67
Total Value
$380.10K
Shares Held After
44,057
% of Holdings
6.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
25,000
Price
$80.17
Total Value
$2.00M
Shares Held After
830,073
% of Holdings
2.9%
ALUMIS INC. (ALMS)
Pangali Sanam — Chief Legal Officer
Shares
5,000
Price
$28.00
Total Value
$140.00K
Shares Held After
11,111
% of Holdings
31.0%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
30,000
Price
$123.72
Total Value
$3.71M
Shares Held After
324,879
% of Holdings
8.5%
Oric Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
300
Price
$12.00
Total Value
$3.60K
Shares Held After
212,772
% of Holdings
0.1%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
7,448
Price
$110.60
Total Value
$823.75K
Shares Held After
60,486
% of Holdings
11.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
4,854
Price
$109.02
Total Value
$529.18K
Shares Held After
67,934
% of Holdings
6.7%
Larimar Therapeutics, Inc. (LRMR)
Hamilton Thomas Edward — Director
Shares
50,000
Price
$3.34
Total Value
$166.89K
Shares Held After
714,798
% of Holdings
7.0%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
1,400
Price
$17.04
Total Value
$23.86K
Shares Held After
9,173,053
% of Holdings
0.0%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
600
Price
$36.02
Total Value
$21.61K
Shares Held After
88,240
% of Holdings
0.7%
Damora Therapeutics, Inc. (DMRA)
Winslow Garrett — General Counsel
Shares
245
Price
$29.98
Total Value
$7.35K
Shares Held After
2,289
% of Holdings
9.7%
NovaBridge Biosciences (NBP)
Xu Cong Claire — SVP, Clinical Development
Shares
4,485
Price
$0.89
Total Value
$3.99K
Shares Held After
298,101
% of Holdings
1.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
83,094
Price
$24.11
Total Value
$2.00M
Shares Held After
125,410
% of Holdings
39.9%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
8,506
Price
$13.96
Total Value
$118.74K
Shares Held After
146,305
% of Holdings
5.5%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
817
Price
$13.96
Total Value
$11.41K
Shares Held After
706,556
% of Holdings
0.1%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
10,000
Price
$38.00
Total Value
$380.00K
Shares Held After
2,700,000
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
17,400
Price
$8.50
Total Value
$147.90K
Shares Held After
1,393,653
% of Holdings
1.2%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
920
Price
$1.88
Total Value
$1.73K
Shares Held After
2,896
% of Holdings
24.1%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
255
Price
$4.31
Total Value
$1.10K
Shares Held After
94,375
% of Holdings
0.3%
Sionna Therapeutics, Inc. (SION)
Fitzpatrick Jennifer — Chief Legal Officer
Shares
10,250
Price
$43.60
Total Value
$446.86K
Shares Held After
0
% of Holdings
100.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
400
Price
$24.13
Total Value
$9.65K
Shares Held After
67,845
% of Holdings
0.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
5,600
Price
$23.25
Total Value
$130.20K
Shares Held After
68,245
% of Holdings
7.6%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
104
Price
$4.31
Total Value
$448.24
Shares Held After
64,441
% of Holdings
0.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
1,737
Price
$4.31
Total Value
$7.49K
Shares Held After
603,671
% of Holdings
0.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
333
Price
$4.34
Total Value
$1.45K
Shares Held After
91,052
% of Holdings
0.4%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
43
Price
$4.31
Total Value
$185.33
Shares Held After
91,385
% of Holdings
0.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
532
Price
$4.31
Total Value
$2.29K
Shares Held After
157,171
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
306
Price
$553.90
Total Value
$169.49K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
135
Price
$553.39
Total Value
$74.71K
Shares Held After
40,819
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
131
Price
$551.88
Total Value
$72.30K
Shares Held After
40,954
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
329
Price
$550.78
Total Value
$181.21K
Shares Held After
41,085
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,116
Price
$549.87
Total Value
$1.16M
Shares Held After
41,414
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,354
Price
$549.03
Total Value
$1.84M
Shares Held After
43,530
% of Holdings
7.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,031
Price
$548.00
Total Value
$564.99K
Shares Held After
46,884
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,098
Price
$546.93
Total Value
$1.15M
Shares Held After
47,915
% of Holdings
4.2%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,270
Price
$14.00
Total Value
$31.78K
Shares Held After
90,180
% of Holdings
2.5%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
2,087
Price
$57.76
Total Value
$120.55K
Shares Held After
104,395
% of Holdings
2.0%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
7,913
Price
$57.16
Total Value
$452.28K
Shares Held After
106,482
% of Holdings
6.9%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$54.03
Total Value
$109.90K
Shares Held After
227,490
% of Holdings
0.9%
Showing 1–50 of 166 transactions (page 1 of 4)